David Brower, MBA

Chief Business Officer

David Brower joined Accent in September 2018 and serves as our Chief Business Officer, responsible for business development, portfolio strategy, and finance at Accent. David has held a range of life science business development, strategy, and investing roles. Prior to joining Accent, David led the business development function for Blueprint Medicines, where he completed a variety of strategic transactions, including its seminal partnerships with Roche Pharmaceuticals, CStone Pharmaceuticals, and Alexion Pharmaceuticals. Prior to Blueprint Medicines, David was a member of Pfizer Pharmaceuticals’ Worldwide Business Development team, focusing on licensing and M&A transactions and business development strategy. He was previously a healthcare trader and investor for Lehman Brothers and Barclays Capital. David received his MBA with a concentration in healthcare from the Wharton School of Business at the University of Pennsylvania and his BA in biology from Dartmouth College.

David Brower Headshot
Wave shape